Drug Master Files for: cisatracurium besylate
✉ Email this page to a colleague
cisatracurium besylate Drug Master Files
| DMF No. | Status | Type | Submission Date | Holder | Subject |
|---|---|---|---|---|---|
| 22962 | A | II | 7/21/2009 | GLAND PHARMA LTD | CISATRACURIUM BESYLATE |
| 23130 | A | II | 9/28/2009 | TEVA PHARMACEUTICAL INDUSTRIES LTD | CISATRACURIUM BESYLATE |
| 23554 | A | II | 2/21/2010 | WAVELENGTH ENTERPRISES LTD | CISATRACURIUM BESYLATE |
| 24033 | I | II | 7/14/2010 | ALP PHARM BEIJING CO LTD | CISATRACURIUM BESYLATE |
| 24902 | A | II | 8/27/2012 | CF PHARMA LTD | CISATRACURIUM BESYLATE VERSION FA1 |
| 24969 | A | II | 8/27/2012 | CF PHARMA LTD | CISATRACURIUM BESYLATE |
| 24999 | A | II | 5/30/2011 | FARMHISPANIA SA | CISATRACURIUM BESYLATE USP |
| >DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information
